91 related articles for article (PubMed ID: 20450582)
1. [Insulin induces anticancer cytotoxicity of 5-Fu to two human colon cancer cell lines].
Ma W; Wang LX; Wang RL; Fan QX; Lu SX
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):169-72. PubMed ID: 20450582
[TBL] [Abstract][Full Text] [Related]
2. Effect of an omega-3 fatty acid containing lipid emulsion alone and in combination with 5-fluorouracil (5-FU) on growth of the colon cancer cell line Caco-2.
Jordan A; Stein J
Eur J Nutr; 2003 Dec; 42(6):324-31. PubMed ID: 14673605
[TBL] [Abstract][Full Text] [Related]
3. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
5. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
[TBL] [Abstract][Full Text] [Related]
6. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Morley KL; Ferguson PJ; Koropatnick J
Cancer Lett; 2007 Jun; 251(1):168-78. PubMed ID: 17197076
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of 5-fluorouracil on HT-1080 human fibrosarcoma cells in vitro].
Liu HW; Niu XH; Xu HR; Zhang Q; Ding Y; Wang Q
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):889-93. PubMed ID: 23336373
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines.
McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ
Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
[TBL] [Abstract][Full Text] [Related]
10. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
[TBL] [Abstract][Full Text] [Related]
11. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
12. [Serum factors in cancer patients affecting the antitumor effect of 5-fluorouracil].
Miwa M; Kojima T; Naruse T
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1591-4. PubMed ID: 9725053
[TBL] [Abstract][Full Text] [Related]
13. The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.
Ojima E; Inoue Y; Watanabe H; Hiro J; Toiyama Y; Miki C; Kusunoki M
Oncol Rep; 2006 Nov; 16(5):1085-91. PubMed ID: 17016597
[TBL] [Abstract][Full Text] [Related]
14. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the N-methoxyindole-3-carbinol (NI3C)--induced cell cycle arrest in human colon cancer cell lines.
Neave AS; Sarup SM; Seidelin M; Duus F; Vang O
Toxicol Sci; 2005 Jan; 83(1):126-35. PubMed ID: 15483186
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with insulin enhances anticancer functions of 5-fluorouracil in human esophageal and colonic cancer cells.
Zou K; Ju JH; Xie H
Acta Pharmacol Sin; 2007 May; 28(5):721-30. PubMed ID: 17439729
[TBL] [Abstract][Full Text] [Related]
19. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Réti A; Pap E; Adleff V; Jeney A; Kralovánszky J; Budai B
Cancer Chemother Pharmacol; 2010 Jul; 66(2):219-27. PubMed ID: 19830428
[TBL] [Abstract][Full Text] [Related]
20. Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells.
Bernhaus A; Fritzer-Szekeres M; Grusch M; Saiko P; Krupitza G; Venkateswarlu S; Trimurtulu G; Jaeger W; Szekeres T
Cancer Lett; 2009 Feb; 274(2):299-304. PubMed ID: 18952370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
